In-Situ Therapeutic Cancer Vaccine for Metastatic Cancer Combining AlloStim With Tumor Cryoablation
Ontology highlight
ABSTRACT: This is a Phase I/II study to investigate the feasibility of creating a personalized therapeutic cancer vaccine within the body. A vaccine contains a source of tumor antigen and an adjuvant. In this study, tumor antigen is generated by freezing a tumor by a minimally invasive percutaneous (through the skin) cryoablation procedure. The study drug, AlloStim, is injected into the ablated tumor to promote development of an anti-tumor immune response.
DISEASE(S): Neoplasm Metastasis,Lung Cancer,Neoplasms, Second Primary,Melanoma,Colorectal Cancer,Prostate Cancer,Breast Cancer,Metastatic Cancer,Neoplasms
PROVIDER: 2069261 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA